Torthaí cuardaigh - Rob Pieters

Beachtaigh na torthaí
  1. 1
    How I treat infant leukemia

    How I treat infant leukemia de réir Patrick A. Brown, Rob Pieters, Andrea Biondi

    Foilsithe / Cruthaithe 2018
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  2. 2
    Advancing Diagnostics and Therapy to Reach Universal Cure in Childhood ALL

    Advancing Diagnostics and Therapy to Reach Universal Cure in Childhood ALL de réir Rob Pieters, Charles G. Mullighan, Stephen P. Hunger

    Foilsithe / Cruthaithe 2023
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  3. 3
    Myocyte enhancer factor 2C in hematopoiesis and leukemia

    Myocyte enhancer factor 2C in hematopoiesis and leukemia de réir Kirsten Canté-Barrett, Rob Pieters, Jules P.P. Meijerink

    Foilsithe / Cruthaithe 2013
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  4. 4
    Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia

    Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia de réir Rob Pieters, D. R. Huismans, A. Leyva, A. Veerman

    Foilsithe / Cruthaithe 1989
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  5. 5
    Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristine

    Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristine de réir Annelies Hartman, Cor van den Bos, Theo Stijnen, Rob Pieters

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  6. 6
    B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment

    B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment de réir Roel Polak, Bob de Rooij, Rob Pieters, Monique L. den Boer

    Foilsithe / Cruthaithe 2015
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  7. 7
    Molecular‐genetic insights in paediatric T‐cell acute lymphoblastic leukaemia

    Molecular‐genetic insights in paediatric T‐cell acute lymphoblastic leukaemia de réir Pieter Van Vlierberghe, Rob Pieters, H. Berna Beverloo, Jules P.P. Meijerink

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  8. 8
    The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia

    The relevance of PTEN-AKT in relation to NOTCH1-directed treatment strategies in T-cell acute lymphoblastic leukemia de réir Rui D. Mendes, Kirsten Canté-Barrett, Rob Pieters, Jules P.P. Meijerink

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  9. 9
    Allergic‐like reactions to asparaginase: Atypical allergies without asparaginase inactivation

    Allergic‐like reactions to asparaginase: Atypical allergies without asparaginase inactivation de réir Robin Q.H. Kloos, Rob Pieters, Gabriele Escherich, Inge M. van der Sluis

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  10. 10
    Tunneling nanotubes facilitate autophagosome transfer in the leukemic niche

    Tunneling nanotubes facilitate autophagosome transfer in the leukemic niche de réir Bob de Rooij, Roel Polak, Femke Stalpers, Rob Pieters, Monique L. den Boer

    Foilsithe / Cruthaithe 2017
    Faigh an téacs iomlán Faigh an téacs iomlán
    Carta
    Cuir le mo chuid Ceanán
    Sábháilte in:
  11. 11
    Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia

    Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia de réir Trudy Buitenkamp, Ron A. A. Mathôt, Valérie de Haas, Rob Pieters, C. Michel Zwaan

    Foilsithe / Cruthaithe 2010
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  12. 12
    Biological background of pediatric medulloblastoma and ependymoma: A review from a translational research perspective

    Biological background of pediatric medulloblastoma and ependymoma: A review from a translational research perspective de réir Judith M. de Bont, Roger J. Packer, Erna Michiels, Monique L. den Boer, Rob Pieters

    Foilsithe / Cruthaithe 2008
    Faigh an téacs iomlán Faigh an téacs iomlán
    Revisão
    Cuir le mo chuid Ceanán
    Sábháilte in:
  13. 13
    Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study

    Favorable prognosis of hyperdiploid common acute lymphoblastic leukemia may be explained by sensitivity to antimetabolites and other drugs: results of an in vitro study de réir Gertjan J.L. Kaspers, LA Smets, Rob Pieters, CH Van Zantwijk, ER van Wering, A. Veerman

    Foilsithe / Cruthaithe 1995
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  14. 14
    Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia

    Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia de réir Amy de Haar-Holleman, Monique L. den Boer, Karin M. Kazemier, Gritta Janka‐Schaub, Rob Pieters

    Foilsithe / Cruthaithe 2003
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  15. 15
    In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions

    In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions de réir Rob Pieters, AH Loonen, DR Huismans, GJ Broekema, MW Dirven, MW Heyenbrok, K. Hählen, A. Veerman

    Foilsithe / Cruthaithe 1990
    Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  16. 16
    Prognostic significance of high-level FLT3 expression in MLL-rearranged infant acute lymphoblastic leukemia

    Prognostic significance of high-level FLT3 expression in MLL-rearranged infant acute lymphoblastic leukemia de réir Ronald W. Stam, Pauline Schneider, Paola De Lorenzo, Maria Grazia Valsecchi, Monique L. den Boer, Rob Pieters

    Foilsithe / Cruthaithe 2007
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  17. 17
    MEK inhibition is a promising therapeutic strategy for <i>MLL</i>-rearranged infant acute lymphoblastic leukemia patients carrying <i>RAS</i> mutations

    MEK inhibition is a promising therapeutic strategy for <i>MLL</i>-rearranged infant acute lymphoblastic leukemia patients carrying <i>RAS</i> mutations de réir Mark Kerstjens, Emma M. C. Driessen, Merel Willekes, Sandra S. Pinhanços, Pauline Schneider, Rob Pieters, Ronald W. Stam

    Foilsithe / Cruthaithe 2016
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  18. 18
    T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies

    T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies de réir Valentina Cordo’, Jordy C.G. van der Zwet, Kirsten Canté-Barrett, Rob Pieters, Jules P.P. Meijerink

    Foilsithe / Cruthaithe 2020
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  19. 19
    MLL fusion-driven activation of<i>CDK6</i>potentiates proliferation in<i>MLL-</i>rearranged infant ALL

    MLL fusion-driven activation of<i>CDK6</i>potentiates proliferation in<i>MLL-</i>rearranged infant ALL de réir Marieke van der Linden, Merel Willekes, Eddy van Roon, Lidija Seslija, Pauline Schneider, Rob Pieters, Ronald W. Stam

    Foilsithe / Cruthaithe 2014
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:
  20. 20
    Up-regulation of asparagine synthetase expression is not linked to the clinical response l-asparaginase in pediatric acute lymphoblastic leukemia

    Up-regulation of asparagine synthetase expression is not linked to the clinical response l-asparaginase in pediatric acute lymphoblastic leukemia de réir Inge M. Appel, Monique L. den Boer, Jules P.P. Meijerink, A. Veerman, Nathalie C. M. Reniers, Rob Pieters

    Foilsithe / Cruthaithe 2006
    Faigh an téacs iomlán Faigh an téacs iomlán
    Artigo
    Cuir le mo chuid Ceanán
    Sábháilte in:

Uirlisí cuardaigh: